Mutations of the JAK1/JAK2 gene, found in tumor cells, promote excessive activation of the STAT family, leading to abnormal cell surface IFN-γ receptors, which are insensitive to IFN-γ secreted by cytotoxic T cells [141]. The gene discussed is IFNG; the disease is neoplasm.